Aquatic Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-13,632
Closed -$1.49M – 1523
2026
Q1
$1.49M Buy
+13,632
New +$1.3M 0.04% 458
2025
Q4
– Sell
-3,469
Closed -$304K – 1603
2025
Q3
$304K Buy
+3,469
New +$310K 0.01% 998
2024
Q1
– Sell
-2,400
Closed -$136K – 1451
2023
Q4
$136K Buy
+2,400
New +$126K ﹤0.01% 938
2023
Q3
– Sell
-600
Closed -$40K – 1473
2023
Q2
$40K Sell
600
-1,000
-63% -$61K ﹤0.01% 1031
2023
Q1
$82K Buy
+1,600
New +$77.7K 0.01% 791
2022
Q1
– Sell
-200
Closed -$10K – 1318
2021
Q4
$10K Buy
+200
New +$10.3K 0.02% 796

Other funds holding LMAT

Aquatic Capital Management's LMAT Position: Q2 2026 in Review

Aquatic Capital Management sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 13,632 shares — an estimated $1.49M sold.

Aquatic Capital Management first reported a position in LMAT in Q4 2021 and held it in 6 quarters. The position peaked at $1.49M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Aquatic Capital Management reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 13,632 LeMaitre Vascular shares in Q2 2026, an estimated $1.49M.
  • Aquatic Capital Management first reported a position in LeMaitre Vascular in Q4 2021 and held it in 6 quarters.
  • Aquatic Capital Management's LeMaitre Vascular position peaked at $1.49M in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.